Centuple Global, a company in the Pharmaceuticals industry, reported revenue of ₹279 crore and a net loss of ₹0.48 crore for the March 2026 quarter.
Centuple Global (BSE: CENTUPLE) closed at ₹32.30 on 20 Nov 2026, down 63.4% over the past year. Its market capitalisation is ₹18 crore.
Incorporated in 1991, Checkpoint Trends Ltd is in the business of trading and consultancy
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.